Researchers at Boston University have developed an artificial intelligence tool that can predict with nearly 80% accuracy whether someone is at risk for developing Alzheimer’s disease based on their speech patterns. The ability to identify potential cognitive decline early has significant potential for mitigating the progression of Alzheimer’s, experts say. The sample size used in the study was small, and experts caution that the tool should not be leaned on as an exclusive method.
The study focused on a cohort of 166 people, between the ages of 63 and 97, who had some level of cognitive complaints. By analyzing hour-long interviews conducted as part of the Framingham Heart Study, researchers were able to track connections between speech patterns and cognitive decline. The AI model they developed was able to predict significant cognitive decline with 78.5% accuracy. Melissa Lee, PhD, from the Alzheimer’s Drug Discovery Foundation, believes that with a larger dataset, the accuracy of the tool could potentially increase even further.
Alzheimer’s disease directly affects more than 55 million people worldwide, with up to 70% of those affected having the disease. The most common symptoms of Alzheimer’s include memory loss, cognitive deficits, problems with speech and recognition, changes in personality, and behavior. Since there is no cure for the disease, patients and caregivers must rely on medication, lifestyle changes, and support groups for treatment.
Using artificial intelligence to detect Alzheimer’s early offers significant advantages to doctors and patients. Early intervention with treatments to slow the disease, improved accessibility to cognitive assessments, and personalized care plans based on predicted disease trajectories are some of the benefits of using AI tools. Healthcare providers can prioritize patients needing intensive monitoring, optimize resource allocation, and refine predictive models using valuable data.
While the nearly 80% accuracy rate of the AI tool is high, there is still a potential for false positives or negatives, which could lead to undue stress or false reassurance for patients. Automating healthcare in such a way could create problems if clinicians over-rely on AI predictions without considering the broader clinical context. It is important to remember that the AI tool is not meant to be used alone, but in conjunction with other diagnostic methods.
Ultimately, the AI tool developed by Boston University researchers is a promising step in predicting cognitive decline in individuals at risk of developing Alzheimer’s disease. By analyzing speech patterns, researchers were able to accurately predict significant cognitive decline in a small sample size. While there is potential for further development and improved accuracy in larger datasets, it is important to use the tool alongside other diagnostic methods to mitigate risks of false predictions and provide a more holistic view of an individual’s health status.
